Stock PBM PSYENCE BIOMEDICAL LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Psyence Biomedical Ltd.

Equities

PBM

CA74449F1009

End-of-day quote Nasdaq
Other stock markets
 03:30:00 01/07/2024 am IST 		5-day change 1st Jan Change
0.319 USD +6.33% Intraday chart for Psyence Biomedical Ltd. -13.27% -96.55%
18/03 Psyence Biomedical Ltd. Announces Results of Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin CI
12/03 Psyence Biomedical Ltd. Receives Human Research Ethics Committee Approval to Initiate Phase IIb Study CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Psyence Biomedical Ltd. Announces Results of Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin
Psyence Biomedical Ltd. Receives Human Research Ethics Committee Approval to Initiate Phase IIb Study
Psyence Biomedical Ltd. Appoints Neil Maresky as CEO
Psyence Biomedical Ltd. Announces Board Appointments
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PBM Stock
  4. News Psyence Biomedical Ltd.
  5. Other languages